Welcome to our dedicated page for BF SEC filings (Ticker: BF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Brown-Forman’s story starts in a charred oak barrel, but the numbers that matter to investors live in the company’s SEC filings. From how long Jack Daniel’s whiskey ages to the currency impact on tequila sales, each document captures details you won’t find on the bottle label. If you have ever searched for Brown-Forman insider trading Form 4 transactions or wondered why barrel inventories shift quarter to quarter, you know the complexity hidden behind the heritage.
Stock Titan delivers those insights instantly. Our platform posts every Brown-Forman quarterly earnings report 10-Q filing, Brown-Forman annual report 10-K simplified, and Brown-Forman 8-K material events explained within minutes of hitting EDGAR. AI-powered summaries translate technical footnotes on agave pricing into plain language, while real-time alerts flag Brown-Forman Form 4 insider transactions real-time and other Brown-Forman executive stock transactions Form 4. Need to assess marketing spend trends? Our dashboards link line-items to narrative sections so you can move from data to decision in one view.
Whether you’re comparing margins across whiskey and tequila segments, reviewing the Brown-Forman proxy statement executive compensation, or simply understanding Brown-Forman SEC documents with AI, this page keeps you ahead. Use the built-in models for Brown-Forman earnings report filing analysis, export tables for valuation work, and set watchlists for supplier-cost disclosures. Complex regulations stay behind the scenes—what you see are clear answers to real investor questions, with every filing type covered and continuously updated.
On 25 Jul 2025, Brown-Forman (NYSE: BF) filed a Form 4 reporting that Yiannis Pafilis—EVP & President for Europe, Africa and Asia—received 31,317 Stock Appreciation Rights (SARs) on 24 Jul 2025. Each SAR carries a $31.15 exercise price, first becomes exercisable on 1 May 2028 and expires on 30 Apr 2035. The award was coded “A” (grant) and is held directly; no Class A or Class B common shares were bought or sold. The filing reflects routine, compensation-related equity issuance and does not indicate open-market trading by the insider.
